Immune Health: References

September 9, 2010

1. P Ferenci, B Dragosics, H Dittrich et al., “Randomized Controlled Trial of Silymarin Treatment in Patients with Cirrhosis of the Liver,”

1. P Ferenci, B Dragosics, H Dittrich et al., “Randomized Controlled Trial of Silymarin Treatment in Patients with Cirrhosis of the Liver,” Journal of Hepatology,vol. 9, no. 1 (July 1989: 105-13.

2. HP Ammon et al., “Pharmacology of Curcuma longa,” Planta Medica,vol. 57, no. 1 (February 1991): 1-7.

3. RB Arora et al., “Anti-inflammatory Studies on Curcuma longa,” Indian Journal of Medical Research,vol. 59 (1971): 1289.

4. DL Lamm, DR Riggs, “The Potential Application of Allium sativum (Garlic) for the Treatment of Bladder Cancer,” Urology Clinics of North America,vol. 27, no. 1 (February 2000): 157-62. M Thomson, M Ali, “Garlic [Allium sativum]: a Review of Its Potential Use as an Anti-Cancer Agent,” Current Cancer Drug Targets,vol. 3, no. 1 (February 2003): 67-81. E Dorant et al., “Garlic and Its Significance for the Prevention of Cancer in Humans: A Critical View,” British Journal of Cancer,vol. (1993): 424-29.

5. MS Hanafy et al., “Effect of Garlic on Lead Contents in Chicken Tissues,” DTW Dtsch Tierarztl Wochenschr,vol. 101, no. 4 (April 1994): 157-58.

6. G Shiota et al., “Rapid Induction of Hepatocyte Growth Factor mRNA after Administration of Gomisin A, a Lignan Component of Shizandra Fruits,” Res Commun Mol Pathol Pharmacol,vol. 94, no. 2 (November 1996): 141-46. Y Ohtaki Y et al., “Deoxycholic Acid as an Endogenous Risk Factor for Hepatocarcinogenesis and Effects of Gomisin A, a Lignan Component of Schizandra Fruits,” Anticancer Research,vol. 16, no. 2 (March 1996): 751-55.

7. R Chander et al., “Effect of Picroliv on Glutathione Metabolism in Liver and Brain of Mastomys natalensis Infected with Plasmodium berghei,” Indian Journal of Experimental Biology,vol. 30, no. 8 (August 1992): 711-14.

8. H Sherry Chow et al., “Modulatoin of Human Glutathione S-Transferences by Polyphenon E Intervention,” Cancer Epidemiology Biomarkers and Prevention, DOI 10:1158/1055-9965 EPI-06-0830.